Key Takeaways
- Medical device distributors, rep agencies, and manufacturers qualify for Bankable
- SBA business loans unavailable to E-3 holders regardless of FDA clearance
- Inventory, working capital, and sales team capital all fundable
- Medical device sales cycles create AR float that Bankable bridges
- 48-hour decisions up to $3M
Australia has a strong medical device industry — Cochlear (hearing implants), ResMed (sleep apnea devices), and Nanosonics (infection control) are globally significant companies. E-3 holders in medical devices often work for or have connections to Australian device companies entering US markets, and many establish independent distribution or rep agency businesses.
Medical device businesses require capital for: device inventory (which must be purchased before consignment or sale), clinical demonstration equipment, sales team investment, and working capital to bridge hospital payment terms (often Net-60 to Net-90). Bankable funds against sales revenue regardless of visa status.
The E-3 Funding Barrier
The SBA's 100% citizen/national ownership rule disqualifies every E-3 holder from government-backed loans — regardless of how long you've been in the US, how profitable your business is, or how strong your credit score is. Banks that primarily originate SBA loans have no viable product to offer you. That's not a reflection of your business quality; it's a policy gap that Bankable was built to bridge.
Revenue-based funding through Bankable requires no green card, no citizenship, and no SBA involvement. What matters: your business generates consistent revenue, has been operating for at least 6 months, and has a US business bank account. That's the core of what we evaluate. Check your Bankability Score to see your options in minutes.
Challenges in This Sector
- Medical device inventory for distribution requires significant upfront capital
- Hospital and healthcare system payment terms run Net-60 to Net-90
- FDA clearance and registration processes are expensive and time-consuming
- Clinical demonstration units must be purchased before generating revenue
- Medical sales representative salaries plus expense accounts are substantial
- Regulatory compliance (FDA QSR, MDR) requires ongoing investment
Funding Solutions for E-3 Holders
- Inventory Financing: Medical device inventory for distribution and consignment programs.
- AR Bridge: Cover hospital payment terms (Net-60 to Net-90) with working capital.
- Sales Team Capital: Fund medical device sales representative hiring.
- Demo Equipment: Clinical demonstration and trial unit capital.
- Regulatory Investment: FDA clearance and compliance cost funding.
Medical Device Distribution Revenue
Medical device distributors with established hospital and ASC relationships generate predictable monthly sales revenue once product lines are established. A distributor generating $100K+/month in device sales has a strong funding profile for Bankable. The challenge is building to that level — which requires inventory capital and sales infrastructure investment upfront.
Capital Products Available
Revenue-Based Funding
Up to $5M based on your monthly revenue. No green card, no SBA. 48-hour decisions.
Apply Now →Equipment Financing
Asset-backed funding for equipment — available to non-citizen business owners.
Check Eligibility →Frequently Asked Questions
Yes. Medical device business ownership is not restricted by E-3 status.
Device distributors, rep agencies, manufacturers, and medical technology companies with commercial revenue.
Yes. Medical device inventory working capital is a primary use case.
We bridge Net-60 to Net-90 healthcare payment terms with working capital structured around your collection cycle.
Typically $20K+/month in consistent sales revenue over 6 months.
Yes. Sales representative hiring and expenses are valid working capital uses.
Yes. Australian medical device companies establishing US distribution through E-3-operated entities qualify.
Yes. Regulatory submission and clearance costs are valid working capital uses.
48-hour decisions. Funds in 3–5 business days.
Yes. Demo units that drive sales are treated as business assets for financing.